Search results

1. DEVELOPMENT OF NEW CLASS PHOTOACTIVATED ANTICANCER-ANTIFUNGAL COMPOUNDS: CONJUGATES OF GOLD NANOPARTICLE-SUPPORTED QUINO…

Principal investigator: dr hab. Oleh M. Demchuk

Katolicki Uniwersytet Lubelski Jana Pawła II, Wydział Medyczny

Call: OPUS 17, Panel: NZ7

2. Anticancer Trojan horses: Application of the bioconjugation idea to invent new anticancer drugs

Principal investigator: dr Michał Piotr Antoszczak

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

Call: UWERTURA 3, Panel: ST4

3. In vitro anticancer screening of triterpene saponins isolated from beetroot (Beta vulgaris L.) by countercurrent chromat…

Principal investigator: Anna Maria Tekieli

Politechnika Krakowska im. Tadeusza Kościuszki, Wydział Inżynierii i Technologii Chemicznej

Call: PRELUDIUM 22, Panel: NZ9

4. CHIRAL RHENIUM AND RHODIUM COMPLEXES OF ANTICANCER AND ANTIBACTERIAL ACTIVITY: SYNTHESIS, ACTIVITY, AND PHYSICOCHEMICAL …

Principal investigator: prof. Jan Czesław Dobrowolski

Narodowy Instytut Leków

Call: OPUS 24, Panel: NZ7

5. Specific interactions of new antitumor unsymmetrical bisacridines, UAs, with DNA and ABC proteins and their potential to…

Principal investigator: prof. Zofia Mazerska

Politechnika Gdańska

Call: OPUS 17, Panel: NZ7

6. Anticancer activity of novel tubulin polymerization inhibitors obtained by the chemical modification of colchicine

Principal investigator: dr hab. Adam Włodzimierz Huczyński

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

Call: OPUS 11, Panel: ST5

7. Application of Griesbaum Co-ozonolysis in the Synthesis of Iron-Sensitive Conjugates of 1,2,4-Trioxolanes as Anticancer …

Principal investigator: prof. Adam Włodzimierz Huczyński

Uniwersytet im. Adama Mickiewicza w Poznaniu

Call: OPUS 29, Panel: ST5

8. Environmental modulation of CDK4/6 inhibitor efficacy: Impact of mycotoxin alternariol exposure on anti-cancer therapies

Principal investigator: dr Anna Dominika Walczak-Szeffer

Uniwersytet Medyczny w Łodzi

Call: SONATA 20, Panel: NZ5

9. Where Inhibition is not Enough- Development of Innovative Compounds for Targeted Degradation of Extracellular and Membra…

Principal investigator: dr Marcin Skoreński

Politechnika Wrocławska

Call: OPUS 28 (LAP), Panel: NZ5

10. Application of bioconjugation strategy to the synthesis of anticancer Trojan horses

Principal investigator: dr hab. Michał Piotr Antoszczak

Uniwersytet im. Adama Mickiewicza w Poznaniu

Call: OPUS 28, Panel: ST5

11. FA-PROTACs - Design and Synthesis of Compounds Based on Folic Acid for Degradation of Enzyme Involved in Folate Metaboli…

Principal investigator: dr Mateusz Daśko

Politechnika Gdańska

Call: SONATA 20, Panel: NZ5

12. Development and characterization of novel multitargeted organometallic tubulin polymerization inhibitors for enhancing t…

Principal investigator: dr hab. Damian Nestor Plażuk

Uniwersytet Łódzki

Call: OPUS 27, Panel: NZ7

13. Functional and structural analysis of anticancer drugs as protein biosynthesis inhibitors

Principal investigator: dr hab. Witold Szaflarski

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

Call: OPUS 26, Panel: NZ7

14. Investigating the anti-cancerous effect of antioxidant extract from spent coffee grounds on the functioning of normal an…

Principal investigator: Adrianna Maria Piasek

Politechnika Warszawska, Wydział Chemiczny

Call: PRELUDIUM 22, Panel: NZ5

15. Design, Synthesis and Characterization of Functionalized 1,2,4-Trioxanes/Trioxepanes for Antimalarial and Anticancer Use

Principal investigator: dr Mohit Kumar Tiwari

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: SONATINA 7, Panel: NZ7

16. Exploring the anticancer, antibacterial and antifungal potential and underlying mechanism of action of plants used in Po…

Principal investigator: dr Kamila Jadwiga Rachwał

Uniwersytet Przyrodniczy w Lublinie

Call: SONATA 18, Panel: NZ9

17. Allosteric and allosteric-orthosteric bitopic ligands of histamine receptor H4 as a way to increase selectivity and bias…

Principal investigator: prof. Sławomir Hubert Filipek

Uniwersytet Warszawski, Wydział Chemii

Call: OPUS 23, Panel: NZ7

18. Identification of anticancer phytochemicals of dandelion root (Taraxaci radix) based on metabolomics and bioassay-guided…

Principal investigator: Sylwia Irena Pawelec

Instytut Uprawy Nawożenia i Gleboznawstwa - Państwowy Instytut Badawczy

Call: PRELUDIUM 21, Panel: NZ9

19. Structure-guided design of histone demethylase inhibitors for cancer therapy.

Principal investigator: dr Piotr Henryk Małecki

Instytut Chemii Bioorganicznej PAN

Call: SONATA 17, Panel: NZ7

20. Heterocyclization of benzenoid ansamycins core as useful strategy for designing anticancer agents

Principal investigator: Natalia Anna Skrzypczak

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

Call: PRELUDIUM 20, Panel: ST4

21. Switchable with visible light cisplatin analogs and complexes of selected transition metals - photochemical and anticanc…

Principal investigator: prof. Krzysztof Szczubiałka

Uniwersytet Jagielloński, Wydział Chemii

Call: OPUS 21, Panel: NZ7

22. Mitochondria-targeting conjugates as a new anticancer agents

Principal investigator: prof. Adam Włodzimierz Huczyński

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

Call: OPUS 21, Panel: ST4

23. Delivery of immuno-activators to phagocytic cells in order to obtain an anti-tumor response

Principal investigator: dr hab. Tomasz Piotr Rygiel

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: OPUS 20, Panel: NZ7

24. Polymersomes specifically releasing cGAMP and doxorubicin in tumor hypoxic regions as a new anti-cancer therapeutic stra…

Principal investigator: dr hab. Ryszard Smolarczyk

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Call: OPUS 20, Panel: NZ5

25. Lactoferrin and versatile polymers as a tool for selective and targeted delivery of anticancer hydrophobic drugs in the …

Principal investigator: Przemysław Krzysztof Gajda-Morszewski

Uniwersytet Jagielloński, Wydział Chemii

Call: PRELUDIUM 18, Panel: NZ7

26. Anticancer activity mechanism and biotechnological obtaining of rinderol - a novel naphthoquinone derivative

Principal investigator: Mateusz Krzysztof Kawka

Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

Call: PRELUDIUM 17, Panel: NZ7

27. Conjugates of metallacarboranes and short cationic peptides with antibacterial and anticancer activity.

Principal investigator: dr Krzysztof Konrad Fink

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: SONATINA 3, Panel: NZ7

28. Novel human topoisomerase II inhibitors as anticancer agents

Principal investigator: dr Barbara Kaproń

Uniwersytet Medyczny w Lublinie, Wydział Nauk o Zdrowiu

Call: PRELUDIUM 15, Panel: NZ7

29. New biocatalytic systems: carbon nanomaterial - enzyme, with controlled activity and potential application in anticancer…

Principal investigator: Paulina Erwardt

Uniwersytet Mikołaja Kopernika, Wydział Chemii

Call: PRELUDIUM 14, Panel: ST5

30. Investigations of the anticancer properties of the titanium carbides and nitrides - MXenes phases

Principal investigator: dr Agnieszka Maria Jastrzębska

Politechnika Warszawska, Wydział Inżynierii Materiałowej

Call: SONATA BIS 7, Panel: ST8

31. Evaluation of anticancer properties and molecular mechanisms of action of new hybrid molecules containing uracil skeleto…

Principal investigator: dr Angelika Agata Długosz-Pokorska

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Call: PRELUDIUM 13, Panel: NZ3

32. Chemical modifications of macrocyclic polyketide -geldanamycin opening an access to new alternative anticancer agents in…

Principal investigator: prof. Piotr Przybylski

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

Call: OPUS 13, Panel: ST5

33. Chemical effects in targeted drug delivery: The roles of anticancer drugs, carriers and conjugates on biomimetic membran…

Principal investigator: dr Dorota Maria Nieciecka

Uniwersytet Warszawski, Wydział Chemii

Call: SONATA 12, Panel: ST4

34. Biological response induced by high antitumor active unsymmetrical bisacridines against human colon and lung cancers and…

Principal investigator: dr hab. Ewa Anna Augustin

Politechnika Gdańska, Wydział Chemiczny

Call: OPUS 12, Panel: NZ7

35. Investigation of the chemical composition and mechanisms of antitumor activity of extracts and chemical substances isola…

Principal investigator: prof. Walerij Isidorow

POLITECHNIKA BIAŁOSTOCKA, Zamiejscowy Wydział Leśny w Hajnówce

Call: OPUS 12, Panel: NZ7

36. The second life of salinomycin: Chemo- and regioselective modifications of salinomycin and their influence on the anti-c…

Principal investigator: dr Michał Piotr Antoszczak

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

Call: SONATA 12, Panel: ST5

37. Synthesis and antitumor activity characteristics of new analogues of hop flavonoids

Principal investigator: prof. Mirosław Anioł

Uniwersytet Przyrodniczy we Wrocławiu, Wydział Nauk o Żywności

Call: OPUS 11, Panel: NZ9

38. Tuning anticancer properties of ruthenium polypyridyl complexes towards antimetastatic activity

Principal investigator: dr hab. Małgorzata Brindell

Uniwersytet Jagielloński, Wydział Chemii

Call: OPUS 11, Panel: NZ7

39. New opportunities for use of PERK kinase inhibitors in eIF2alfa factor-dependant signalling pathway in antitumor therapy

Principal investigator: dr Wioletta Julia Rozpędek-Kamińska

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Call: PRELUDIUM 10, Panel: NZ3

40. New MOF compounds as degradable nanocontainers of tyrosine kinases inhibitors in novel anti-cancer therapy

Principal investigator: prof. Artur Piotr Terzyk

Uniwersytet Mikołaja Kopernika, Wydział Chemii

Call: OPUS 9, Panel: ST5

41. Characterization of anticancer activity of new synthetic alpha-methylene-delta lactones in cancer cell lines.

Principal investigator: dr hab. Katarzyna Anna Gach-Janczak

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Call: SONATA 9, Panel: NZ3

42. Synthesis and study of anticancer activities and affinities to kinesin of selected sandwich and half-sandwich organometa…

Principal investigator: dr hab. Damian Nestor Plażuk

Uniwersytet Łódzki, Wydział Chemii

Call: OPUS 9, Panel: ST5

43. Enzymatic catalysis as a versatile tool for the synthesis of 1,3-dimethylxanthine derivatives with potential anticancer …

Principal investigator: dr Paweł Borowiecki

Politechnika Warszawska, Politechnika Warszawska

Call: PRELUDIUM 7, Panel: ST5

44. Cellular and molecular mechanism of action of PPI dendrimer complexes with nucleoside analogue anticancer drugs

Principal investigator: prof. Barbara Teresa Klajnert-Maculewicz

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: OPUS 7, Panel: NZ3

45. Applications of High Resolution Magic Angle Spinning Spectroscopy in research of selected anticancer drug embedded in me…

Principal investigator: Ewa Agnieszka Skorupska

Centrum Badań Molekularnych i Makromolekularnych PAN

Call: PRELUDIUM 7, Panel: ST5

46. cycloaddition reactions in the synthesis of a novel anticancer active ferrocenyl heterocycles

Principal investigator: dr Anna Katarzyna Wieczorek-Błauż

Uniwersytet Łódzki, Wydział Chemii

Call: PRELUDIUM 6, Panel: ST5

47. The impact of P450 and UGT isoenzyme overexpression on cellular response induced by antitumor acridinone derivatives. Th…

Principal investigator: prof. Zofia Mazerska

Politechnika Gdańska, Wydział Chemiczny

Call: OPUS 5, Panel: NZ3

48. New polynitrogen 2-mercaptobenzenesulfonamide derivatives with anticancer potency - synthesis, activity evaluation and d…

Principal investigator: prof. Jarosław Jerzy Sławiński

Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

Call: OPUS 5, Panel: NZ7

49. Designing mRNA transcripts resistant to enzymatic cap hydrolysis applicable for anti-cancer vaccines; multiplexed bioche…

Principal investigator: prof. Edward Darżynkiewicz

Uniwersytet Warszawski

Call: MAESTRO 4, Panel: NZ1

50. Synthesis and anticancer activity of octahydropyrazin[2, 1-a:5,4-a']diisoquinoline deratives

Principal investigator: prof. Krzysztof Bogusław Bielawski

Uniwersytet Medyczny w Białymstoku, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

Call: OPUS 4, Panel: NZ7

Projects search